survive for 5 years or longer These survival rates are for endometrial cancer in general and aren’t specific to platinum-resistant endometrial cancer. Platinum resistance makes treating ...

The addition of radiation to chemotherapy did not improve overall survival in patients with locally advanced endometrial cancer, a recent phase 3 trial found.

Cancer rates are declining, but young women are being diagnosed more frequently. Learn about the current trends and research ...

Here are the top 5 most common forms of cancers that can hit your immune system as soon as you cross 30. Check out the cancer ...

The EC has approved GSK's Jemperli (dostarlimab) combined with chemotherapy for primary advanced or recurrent endometrial ...

Overweight and obesity were associated with improved survival after treatment of endometrial cancer with immunotherapy, especially in high-risk subtypes, when compared to patients with a normal BMI.

Lenvima plus Keytruda did not significantly improve survival or progression-free survival compared to chemotherapy in advanced endometrial cancer. The study involved 842 patients, with no new safety ...

GSK's Jemperli wins EU approval for broader use in advanced endometrial cancer, showing improved survival and significant trial results.

In South Africa, the number of cases of ovarian cancer is predicted to rise by a staggering 72.9% by 2050, underscoring the pressing need for greater awareness among women and clinicians, early ...

Imfinzi recommended for approval in European Union for the treat of adults with limited-stage small cell lung cancer ...

The World Health Organisation (WHO) has warned of a rising cancer burden, particularly in the South-East Asia region, where 2 ...